Watson, A. L., Keller, B. J., Williams, K. A., Damle, N. N., Finnerty, S. J., Anderson, L. K., . . . Largaespada, D. A. (2020). Correction: Co-targeting the MAPK and PI3K/AKT/mTOR pathways in two genetically engineered mouse models of schwann cell tumors reduces tumor grade and multiplicity. Oncotarget.
Citação norma ChicagoWatson, Adrienne L., et al. "Correction: Co-targeting the MAPK and PI3K/AKT/mTOR Pathways in Two Genetically Engineered Mouse Models of Schwann Cell Tumors Reduces Tumor Grade and Multiplicity." Oncotarget 2020.
Citação norma MLAWatson, Adrienne L., et al. "Correction: Co-targeting the MAPK and PI3K/AKT/mTOR Pathways in Two Genetically Engineered Mouse Models of Schwann Cell Tumors Reduces Tumor Grade and Multiplicity." Oncotarget 2020.